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L eptomeningeal carcinomatosis (LC) is the multi-focal spreading of malignant tumour cells along 
the meninges.  LC occurs in 5% of all patients diag-
nosed with cancer,  but rarely in patients with gastric 
cancer [1 , 2].  Almost all patients with LC have already 
been diagnosed with advanced cancers with distant 
metastases and present neurological symptoms,  such as 
cranial nerve palsies,  headache,  psychiatric symptoms,  
quadriplegia,  nausea,  and vomiting [3].  Although the 
cytologic examination of cerebral spinal fluid (CSF) is 
the gold standard for the diagnosis of LC,  its sensitivity 
reaches only 90%,  even after repeated tests [4].  Several 
reports have shown the utility of tumour marker levels 
in CSF to diagnose LC in patients with cancer,  com-
pared with the cytologic examination of CSF [5-7].  
Here,  we report a patient with LC as an initial 
symptom of gastric cancer.  Her carcinoembryonic anti-
gen (CEA) level in CSF facilitated the LC diagnosis 
because no malignant cells were found in a total of three 
rounds of CSF cytologic examination.
Case Description
A 77-year-old woman who had suffered from 
anorexia for 3 weeks and bilateral lower extremity 
weakness for a few days was admitted to our hospital.  
She presented with general malaise,  mild posterior neck 
pain,  and gait disturbance,  but had no headache or 
digestive symptoms.  Her consciousness was clear,  and 
her vital signs included a body temperature of 36.7°C,  
blood pressure of 189/95 mmHg,  pulse rate of 73/min,  
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A 77-year-old woman with no history of malignancy presented with anorexia and bilateral lower extremity 
weakness.  Her consciousness level worsened daily,  so we performed a lumbar puncture.  Cerebrospinal fluid 
(CSF) analysis indicated meningitis,  but three rounds of CSF cytology showed no malignant cells.  The patient’s 
carcinoembryonic antigen (CEA) level was highly elevated in CSF,  but normal in serum.  Through gadolini-
um-enhanced brain/spinal magnetic resonance imaging and gastrointestinal endoscopy,  she was diagnosed 
with leptomeningeal carcinomatosis (LC) from gastric cancer.  CEA level in CSF facilitated the diagnosis of LC 
from gastric cancer because there were no malignant cells on CSF cytology.
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and respiratory rate of 16/min.  She had no neck stiff-
ness or sensory neurologic deficits.  Manual muscle 
testing showed mild quadriceps and iliopsoas weakness.  
Her abdomen was flat and soft,  and no tenderness was 
found.  Her serum CEA level was 2.9 ng/mL.  Whole-
body computed tomography and brain spinal magnetic 
resonance imaging (MRI) without contrast showed no 
specific findings,  including hydrocephalus.  Her level of 
consciousness worsened daily and we therefore per-
formed a lumbar puncture.  Her CSF opening pressure 
was 17 cm H2O.  CSF analysis revealed nine mononu-
clear and four polynuclear cells/μL,  a glucose level of 
27 mg/dL (CSF-blood glucose ratio: 0.18),  and a total 
protein value of 261 mg/dL,  inidicating meningitis.  
CSF gram staining was negative,  a total of three rounds 
of CSF cytology showed no malignant cells,  and her 
CSF CEA level was highly elevated at 117.1 ng/mL.  
Gadolinium-enhanced TI-weighted MRI showed dif-
fuse leptomeningeal contrast enhancement following 
the cortical surface of the cerebrum,  the cerebellar folia,  
and the ventral surface of the brainstem,  as well as lin-
ear and nodular enhancement along the surface of the 
spinal cord and cauda equina,  indicating LC (Fig. 1).  
The patient’s bilateral lower extremity muscle weakness 
was considered to be due to a lesion in the spinal pyra-
midal tract.  When exploring the primary site,  a gastric 
tumor was found by gastrointestinal endoscopy and 
histologically diagnosed as human epidermal growth 
factor receptor 2 (HER2)-negative poorly differentiated 
adenocarcinoma (Fig. 2).  The patient’s level of con-
sciousness deteriorated rapidly,  and she died 25 days 
after admission.
Discussion
We experienced a patient with LC as an initial 
symptom of gastric cancer,  and her CEA levels in CSF 
facilitated the diagnosis of gastric LC.  To the best of our 
knowledge,  this is the first report on the utility of CEA 
levels in CSF for the diagnosis of gastric LC in a patient 
with no malignant cells on cytologic examination of CSF 
and normal serum CEA levels.
LC rarely develops as an initial symptom of gastric 
cancer.  It occurs in approximately 8% of patients with 
solid cancers [1],  but in only 0.17-0.69% of patients 
with gastric cancer [2],  and the majority of patients 
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Fig.  1　 Gadolinium-enhanced T1-weighted MRI 
showing diffuse leptomeningeal contrast enhancement 
following the cortical surface of the cerebrum (A),  the 
cerebellar folia (B),  the ventral surface of the brain-
stem (C),  and linear or nodular enhancement along the 
surface of the spinal cord and cauda equina (D).
with LC have already been diagnosed with advanced 
cancers with distant metastases [3].  The most frequent 
symptoms of LC include cranial nerve palsies (75%),  
headache (66%),  psychiatric symptoms (45%),  quadri-
plegia (44%),  and nausea and vomiting (20%) [2].  
Although there have been previous case reports in 
which LC was an initial symptom of gastric cancer,  the 
patients in these reports had certain neurological symp-
toms [8 , 9].  Because our patient presented with only 
mild symptoms and had no history of malignancy,  we 
did not initially consider the possibility of LC.  A previ-
ous report found that brain metastasis is frequent in 
breast cancer patients with HER2-positive or tri-
ple-negative disease,  and the patients with triple-nega-
tive disease had the worst prognosis [10].  Therefore,  
HER2-negative status in this case might also be associ-
ated with a poor prognosis in gastric cancer patients 
with metastasis to the central nervous system,  as tri-
ple-negative disease in breast cancer.  CEA levels in CSF 
may contribute to the diagnosis of LC,  even if no 
malignant cells are found on cytologic examination.  
Although the cytologic examination of CSF is the gold 
standard for the diagnosis of meningeal carcinomatosis,  
its sensitivity reaches only 90%,  even after repeated 
tests [4].  A previous study reported the utility of CEA 
levels in CSF to diagnose meningeal carcinomatosis in 
patients with cancer,  compared with cytologic exam-
ination as the gold standard [5].  Our patients showed 
no malignant cells in a total of 3 rounds of CSF cyto-
logic examination but showed elevated CEA levels in 
CSF and normal serum CEA levels.  Therefore,  the 
measurement of CEA levels in CSF,  in addition to a 
cytologic examination,  may improve sensitivity for 
diagnosing LC.
In conclusion,  it is uncommon to consider the pos-
sibility of LC in patients who present mild symptoms 
and have no history of malignancy.  However,  CEA 
levels in CSF with cytologic examination may be helpful 
in diagnosing gastric LC,  despite a lack of malignant 
cells on cytologic examination of CSF and normal 
serum CEA levels.
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Fig.  2　 Gastrointestinal endoscopy showing advanced gastric 
cancer.
